Cello Therapeutics' Unattributed Round

Cello Therapeutics raised a round of funding on June 24, 2017.

Cello Therapeutics aims to develop membrane-coated nanoparticle formulations for cancer treatment. These nanoparticles promise safer and more effective drug delivery compared with traditional chemothe…

Articles about Cello Therapeutics' Unattributed Round: